Catheter Precision, Inc. (VTAK) Return on equity 2018–2025
Catheter Precision, Inc. (VTAK) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
-243.6%FY2025 · since FY2018: -46.2% → -243.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -243.6% | -102.0 pp |
| FY2024 | -141.6% | +191.4 pp |
| FY2023 | -333.0% | -42.9 pp |
| FY2022 | -290.1% | -106.8 pp |
| FY2021 | -183.4% | -12.9 pp |
| FY2020 | -170.4% | +1.4 pp |
| FY2019 | -171.8% | -125.6 pp |
| FY2018 | -46.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VTAK financial trends
VTAK RevenueVTAK Net incomeVTAK Net marginVTAK Gross profitVTAK Gross marginVTAK Operating incomeVTAK Operating marginVTAK Operating cash flowVTAK Free cash flowVTAK Capital expendituresVTAK Stock buybacksVTAK Dividends paidVTAK Total assetsVTAK Total liabilitiesVTAK Shareholders’ equityVTAK overview →